In addition to identifying abnormal peptides and HLA typing, antigen-MHC binding affinity is the next focus of tumor antigen prediction.86,87 Human MHC molecules are divided into the following three subtypes: Class I, Class II, and Class III. This evidence concerns the gene HLA-C and neoplasm.